A Drug-Drug Interaction Study of LY3537982 on Midazolam, Digoxin, and Rosuvastatin in Healthy Participants
Clinical trial NCT06111521 · COMPLETED
Trial details
- NCT number
- NCT06111521
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-27
- Primary completion
- 2024-04-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.